Question explored with the scientific record
Does low IgA levels increase risk of breakthrough varicella in vaxed 24 yo woman
The short version: the evidence does not answer your question. No study in this retrieval tested whether low serum IgA levels increase breakthrough varicella in a vaccinated adult.
The retrieved studies cover varicella vaccine effectiveness in outbreaks [4], post-exposure prophylaxis in children [1], and varicella complications in unvaccinated infants [6]. None of them measured serum IgA levels or looked at breakthrough infection risk in a 24-year-old woman. One study on VZV-specific cell-mediated immunity showed that CD4 T-cell responses, not IgA, discriminate between immune and non-immune individuals [5]. That points to cellular immunity, not antibody class, as the relevant defense.
IgA is primarily a mucosal antibody, transported across epithelial surfaces to protect the gut and respiratory tract [2, 3]. Serum IgA, the kind measured in a blood test, is mostly monomeric and plays a minor role in systemic antiviral defense. Varicella is controlled mainly by T-cell responses and IgG antibodies. Low serum IgA alone is unlikely to be the deciding factor. The real question is whether this woman has an underlying immune deficiency that also affects T-cell or IgG responses. Selective IgA deficiency is common and often asymptomatic; many people with it handle viral infections normally.
My call: low serum IgA levels are not known to increase breakthrough varicella risk in vaccinated adults, but the evidence base for that specific question is empty. Confidence: low.
Sources used 6
-
Varicella vaccine in post-exposure prophylaxis
This review finds that post-exposure prophylaxis with Oka-derived varicella vaccines within 3 days of rash onset in the index case appears effective in children, although a small proportion may develop mild but infectious chickenpox especially after household exposure; controlle…
DOI: 10.33321/cdi.2001.25.4 -
The immune landscape of IgA induction in the gut
A comprehensive review of how secretory IgA is induced in the gut, detailing IgA structure, mucosal immune anatomy (PP, ILF, GALT), TD vs TI pathways, IgA induction in Peyer’s patches, non-cognate T cell help, and implications for IgA nephropathy.
DOI: 10.1007/s00281-021-00879-4 -
IgA receptors in health and disease
A comprehensive review detailing the diverse IgA receptors across humans and model organisms, their molecular interactions with IgA (including secretory IgA), cellular distributions, roles in mucosal and systemic immunity, and implications for IgA-associated diseases such as IgA…
DOI: 10.1111/j.1399-0039.2006.00613.x -
Use of vaccination in a large outbreak of primary varicella in a detention setting for African immigrants
This study describes a large outbreak of primary varicella among young adult men in a detention facility for African immigrants in Israel, highlighting the effectiveness of vaccination in controlling the outbreak.
DOI: 10.1093/inthealth/ihu017 -
Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated whole blood cultures
The authors developed a simple 1 mL whole-blood assay to quantify varicella-zoster virus (VZV)-specific cell-mediated immunity by measuring proliferation of responder CD4 high-memory T cells in activated whole-blood cultures, demonstrating discrimination between varicella-immune…
DOI: 10.1016/j.vaccine.2019.07.068 -
Infectious Diseases and Vaccination Strategies: How to Protect the “Unprotectable”?
A retrospective single-center medical record review at Bambino Gesù Children's Hospital found that unvaccinated infants too young for routine vaccination—21 with pertussis (<3 months), 18 with measles (<15 months), and 32 with varicella (<12 months)—experienced substantial morbi…
DOI: 10.5402/2013/765354